PATENT CLAIM ANALYSIS

Application Number: 15978390
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["424", "135100"]

Abstract:
The present invention relates to bispecific constructs that specifically bind to immune effector cells and, simultaneously, to IL23R-carrying target cells, as well as nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production and use thereof, including such bispecific constructs for use in treating inflammatory and/or autoimmune diseases and/or cancer.

Claim (Index 9):
The method of  claim 1 , wherein said first and second binding moieties are arranged relative to each other in such a manner that the part of the first binding moiety recognizing CD3\u03b5 and the part of the second binding moiety recognizing IL23R project, relative to the center of the bispecific construct, outward in essentially opposite directions.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 93.0
- Lexical Diversity: 1.42857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14889225', '15829783', '15604153', '15225107', '15829793']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6861061252681733
- 35 USC 102 Novelty (BERT): 0.6754634797262667
- Combined Prediction Score: 0.6850418607139827
- Mean Citation Score: 362.187456
- Max Citation Score: 680.0639
- Similarity Product: 636.4842703608036

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test